Clinical Trial Update: A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating IOV-4001 for unresectable or metastatic melanoma and stage III/IV non-small cell lung cancer is currently recruiting in adults. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer

Drugs mentioned

• IOV-4001

Snippet

Sponsor: Iovance Biotherapeutics, Inc. | Conditions: Unresectable Melanoma, Metastatic Melanoma | Phase 1, Phase 2 | Status: RECRUITING